Patent · US Active

CD37-binding molecules and immunoconjugates thereof

US11466095B2 · kind B2 · utility

1Cited by

12References

21Claims

0Family size

Assignee

Debiopharm International S.A.

Inventors

Jutta Deckert · Lexington, US
Peter U. Park · Lexington, US
Daniel Tavares · Natick, US
Lingyun Rui · Weston, US

Key dates

Filing date	Dec 17, 2018
Grant date	Oct 11, 2022
Priority date	—
Expiry date	Aug 6, 2040

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/70596
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Novel anti-cancer agents, including, but not limited to, antibodies and immunoconjugates, that bind to CD37 are provided. Methods of using the agents, antibodies, or immunoconjugates, such as methods of inhibiting tumor growth are further provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.